Prometheus Laboratories Inc.

Prometheus Laboratories Inc., a San Diego-based for-profit diagnostic testing company, supplies reference laboratory testing services and pharmaceutical preparations to the Department of Veterans Affairs and the Department of Defense on a prime-contractor basis, with no subcontract footprint and no socioeconomic set-aside designations. The vendor operates as a standard corporate entity registered with SAM.gov since January 2002, competing full-and-open across military medical and VA healthcare networks.

Prometheus specializes in gastroenterology diagnostic testing, reference laboratory services, and pharmaceutical preparation manufacturing for federal healthcare programs. Representative work includes a $125 thousand single-award IDIQ with Veterans Integrated Service Network 10 for various gastroenterology testing services (award date September 28, 2022, running through September 18, 2027), under which VISN 10 has issued multiple delivery orders including $114,926.50 (September 2023), $125 thousand (September 2024), and $125 thousand (September 2025), all on firm fixed-price terms with performance in San Diego, California. The vendor also delivers gastroenterology diagnostic services to VA medical facilities across California, Nevada, and Michigan through additional VISN agreements. Recent activity includes a $19,936.50 delivery order from VISN 10 in September 2026 for gastroenterology and reference laboratory testing services, and a $6,220 purchase order from Veterans Integrated Service Network 20 in September 2024 for gastroenterology diagnostic testing.

Customer concentration splits between VA networks and military medical commands. The top five customers by award count account for 56% of all awards and include the Department of the Navy Bureau of Medicine and Surgery (36 awards, $1.5 million combined potential value), the Department of the Army Medical Command (28 awards, $8.9 million), and three VA networks led by VISN 10 (17 awards, $905 thousand). However, the top-value ranking diverges sharply — Veterans Integrated Service Network 12 anchors $25.2 million across just four awards, suggesting large standing orders or multi-year commitments, while Army Medical Command's 28 awards total $8.9 million. The vendor has worked with 11 distinct federal agencies across its 176-award footprint. Combined potential value stands at $43.7 million, though only $3.2 million has been obligated to date, indicating that most awards carry ceiling values that exceed typical invoicing.

Activity has contracted significantly — two awards in 2022, one in 2023, two in 2024, one in 2025, and one in 2026 — suggesting a declining or stabilized customer base. Just four awards with combined potential value of $270 thousand reach ultimate completion in the next twenty-four months, indicating limited near-term recompete exposure. NAICS concentration sits predominantly within Medical Laboratories (54 awards) and Pharmaceutical Preparation Manufacturing (40 awards), with PSC coding heavily weighted to Reference Laboratory Testing (144 awards). The vendor holds no parent IDIQ, GWAC, or BPA vehicles; all work flows through agency-specific single-award IDIQs and direct purchase orders from VA networks and military medical commands.

Prometheus Biosciences is a forward-thinking biopharmaceutical company that is dedicated to disrupting the treatment paradigm of GI diseases. We will do this by discovering and developing a broad portfolio of novel precision therapeutics and diagnostics that will meaningfully impact patient care.